Morr, a highly effective preparation for hair regrowth for men and women, from Intas Pharmaceuticals Ltd. contains minoxidil 12,5% as an active ingredient. Morr is one of the most inexpensive forms of minoxidil with excellent quality. The brand belongs to Intas Pharmaceuticals Ltd., which has an international GMP (Good Manufacturing Practice) certificate. GMP certificate - evidence of a high level of production and quality of manufactured drugs.
General Information About Minoxidil 12,5% Morr
Morr Forte is manufactured by Halcyon Labs Pvt. Ltd. and is marketed internationally as a brand of a well-known Indian pharmaceutical company Intas Pharmaceuticals Ltd. (India) . Intas Pharmaceuticals Ltd. has an international GMP (Good Manufacturing Practice) certificate. GMP certificate - evidence of a high level of production and quality of manufactured drugs.
Founded in the early 70s of the last century Intas Pharmaceuticals Ltd. has become one of the leaders in the pharmaceutical market in India. From the very beginning, Intas Pharmaceuticals Ltd. has set the development and production of drugs for the treatment of diseases in the field of gastroenterology and the cardiovascular system among the priority tasks. Intas Pharmaceuticals Ltd. has achieved significant success in the development and production of cancer, diabetic, antiviral, hormonal and other drugs. In 2007, the production of the company received accreditation of the US FDA. This suggests that the company's drugs meet the highest requirements of American standards. The quality of the products is also confirmed by other organizations such as MHRA, TGA, ANVISA and MCC. The company currently supplies its drugs to 42 countries around the world.
A Morr solution containing minoxidil 12,5%, when applied topically, should stimulate hair growth in individuals with androgenetic alopecia (male pattern baldness).
Chemically, minoxidil is 2,4-diamino-6-piperidinopyrimidine-3-oxide.
When applied topically, minoxidil solution for external use has been shown to stimulate hair growth in individuals with androgenetic alopecia (male pattern baldness). Although the exact mechanisms of action of minoxidil in the treatment of androgenetic alopecia are not known, there may be several ways this drug can stimulate hair growth. These include:
- Vasodilation of the microvasculature around the hair follicles, which enhances hair growth;
- Direct stimulation of hair follicle cells, which induces them to enter the proliferative phase: follicles in the resting phase (telogen) enter the active phase (anagen);
- Disruption of the effect of androgens on genetically predisposed hair follicles: Minoxidil can interfere with androgen metabolism in the scalp, suppressing the ability of androgens to act on hair follicles.
For the appearance of the expected stimulation of hair growth, it may be necessary to use the drug for 4 or more months. The duration of the onset of drug action and the degree of its activity may differ among patients.
Packaging form, composition and dosage of minoxidil 12,5% Morr
Morr comes in lotion form. One bottle contains 60 ml of the drug. 1 bottle of Morr is designed for 1 month treatment.
The Morr kit includes a pipette and a spray.
Each ml of Morr solution contains:
- Minoxidil IP (International Pharmacopoeia) - 12,5% (w/v)
- Isopropyl alcohol (95%) IP (International Pharmacopoeia) - 40% (v/v)
Indications for the use of minoxidil 12,5% Morr
Morr is used to treat androgenetic alopecia (male pattern baldness) in men between the ages of 18 and 60.
Warnings and special instructions for minoxidil 12,5% Morr
Some absorption of minoxidil from the skin surface creates the possibility of developing systemic effects such as tachycardia, angina pectoris and edema, and an increased likelihood of orthostatic hypotension caused by guanethidine. Patients should be monitored dynamically to identify possible systemic effects of minoxidil. If systemic side effects appear, the drug should be discontinued. If necessary, diuretic drugs should be used to treat fluid retention and edema. Control of tachycardia and angina pectoris is possible by prescribing drugs from the group of beta-blockers or other inhibitors of the activity of the sympathetic nervous system.
Pregnancy and lactation: Preparations based on minoxidil during pregnancy and lactation can only be used as directed by the attending physician.
Childhood: The safety and efficacy of minoxidil-based drugs in patients under 18 years of age has not been established.
Use in patients with concomitant cardiovascular disease: Minoxidil Topical Solution should not be used in patients with known concurrent coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart disease. Patients with hypertension, including those receiving antihypertensive drugs, should be closely monitored. If necessary, it is necessary to correct the treatment. If the patient has any other cardiovascular disease, the solution should be used with caution.
Elderly use: No studies have been performed with people over the age of 60. In this regard, the safety and efficacy of the drug in these patients has not been identified.
How to use minoxidil 12,5% Morr
Morr Topical Solution in a total amount of 1 ml should be applied once or twice a day (depending on the doctor's prescription) to thinning scalp areas, starting in the center of the affected area ... Regardless of the size of the affected area, this dose must be used. The total daily dose of the drug should not exceed 2 ml. Morr Topical Solution should only be applied to completely dry hair and scalp.